Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page
- ChecktodayChange DetectedA new revision label 'Revision: v3.5.5' has been added to the study history, replacing the previous 'Revision: v3.5.4' and indicating an update to the record's revision level.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added to the page history. This replaces the previous 'Revision: v3.5.3' in the history and signals an update to the record's revision metadata.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s software/version footer was updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study history shows a new revision label, v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.5.0 was added to the record history, and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page footer revision label changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.